Key facts
- It has raised $57.5M; the latest was Later Stage VC ($26.9M) in Jul 2024.
- Notable investors include CDP Venture Capital (Rome), European Commission, High-Tech Gründerfonds, b2venture, Endeavor Italy — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for WISE (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for WISE (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About WISE (Therapeutic Devices)
Developer of stretchable electrodes intended to be used in neuro-modulation therapy. The company's products are electrodes and leads that can be surgically implanted to apply electrical stimuli to neural tissues that have thin elastomeric foils with electronic circuits that prevent dislocation, breakage, or damage, enabling patients to treat chronic pain.
- Sector
- Healthcare
- HQ
- Milan, Italy
- Founded
- 2011
- Employees
- 48
- Website
- wiseneuro.com/
- Ownership
- Privately Held (backing)
WISE (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WISE (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WISE (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.